NO20006719L - Vitamin E og estere derav for anvendelse ved topisk behandling av mukopatologier - Google Patents

Vitamin E og estere derav for anvendelse ved topisk behandling av mukopatologier

Info

Publication number
NO20006719L
NO20006719L NO20006719A NO20006719A NO20006719L NO 20006719 L NO20006719 L NO 20006719L NO 20006719 A NO20006719 A NO 20006719A NO 20006719 A NO20006719 A NO 20006719A NO 20006719 L NO20006719 L NO 20006719L
Authority
NO
Norway
Prior art keywords
vitamin
vulvitis
esters
topical treatment
dryness
Prior art date
Application number
NO20006719A
Other languages
English (en)
Other versions
NO20006719D0 (no
Inventor
Eleonora Annunziata
Giorgio Panin
Original Assignee
Giorgio Panin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11380415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20006719(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Giorgio Panin filed Critical Giorgio Panin
Publication of NO20006719D0 publication Critical patent/NO20006719D0/no
Publication of NO20006719L publication Critical patent/NO20006719L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20006719A 1998-07-10 2000-12-29 Vitamin E og estere derav for anvendelse ved topisk behandling av mukopatologier NO20006719L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT98MI001586A ITMI981586A1 (it) 1998-07-10 1998-07-10 Vitamina e e suoi esteri per l'uso nel trattamento topico di patologie delle mucose
PCT/IB1999/001238 WO2000002554A1 (en) 1998-07-10 1999-07-05 Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies

Publications (2)

Publication Number Publication Date
NO20006719D0 NO20006719D0 (no) 2000-12-29
NO20006719L true NO20006719L (no) 2001-02-16

Family

ID=11380415

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006719A NO20006719L (no) 1998-07-10 2000-12-29 Vitamin E og estere derav for anvendelse ved topisk behandling av mukopatologier

Country Status (22)

Country Link
EP (1) EP1094807B1 (no)
JP (1) JP2002520281A (no)
CN (1) CN1135975C (no)
AT (1) ATE238051T1 (no)
AU (1) AU762860B2 (no)
BR (1) BR9911945A (no)
CA (1) CA2336990A1 (no)
CZ (1) CZ301019B6 (no)
DE (1) DE69907193T2 (no)
DK (1) DK1094807T3 (no)
ES (1) ES2196813T3 (no)
HU (1) HU228921B1 (no)
IL (1) IL140759A0 (no)
IT (1) ITMI981586A1 (no)
NO (1) NO20006719L (no)
NZ (1) NZ509129A (no)
PL (1) PL345500A1 (no)
PT (1) PT1094807E (no)
RU (2) RU2221561C2 (no)
SK (1) SK284464B6 (no)
TR (2) TR200100014T2 (no)
WO (1) WO2000002554A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040077604A1 (en) 2001-12-19 2004-04-22 Lenard Lichtenberger Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providingenhanced therapeutic activity
FR2819186A1 (fr) * 2001-01-10 2002-07-12 L M D Cystine-voie orale-syndrome de l'oeil sec
FR2825088A1 (fr) * 2001-05-25 2002-11-29 Derma Dev Nouveaux esters de tocopherol, leurs procedes d'obtention et leurs utilisations
US7485666B2 (en) * 2004-06-17 2009-02-03 Kimberly-Clark Worldwide, Inc. Vaginal health products
US20080038316A1 (en) 2004-10-01 2008-02-14 Wong Vernon G Conveniently implantable sustained release drug compositions
US9993558B2 (en) 2004-10-01 2018-06-12 Ramscor, Inc. Sustained release eye drop formulations
US8541413B2 (en) * 2004-10-01 2013-09-24 Ramscor, Inc. Sustained release eye drop formulations
BRPI0920326A2 (pt) 2008-10-09 2016-02-23 Ramscor Inc composição e método para tratamento da síndrome do olho ressecado
IT1394063B1 (it) * 2009-05-11 2012-05-25 Giuliani Spa Composizione per uso oftalmico adatta al trattamento degli stati infiammatori dell'occhio e della sindrome dell'occhio secco
CA2805511C (en) * 2009-07-27 2017-04-11 Sanseverino, Renato Ophthalmic solution for protecting internal structures of the eyeball against uv-a rays or for the treatment of keratoconus with a trans-epithelial cross-linking technique
KR102162901B1 (ko) 2011-09-29 2020-10-08 피엘엑스 옵코 인코포레이티드 위장관을 따라 약물을 표적화 방출하기 위한 pH 감응성 담체, 그로부터의 조성물, 및 이들의 제조 및 사용 방법
US10251861B2 (en) * 2012-06-08 2019-04-09 Ohio State Innovation Foundation Methods for treating burn and scar injury using tocotrienol compositions
DE202014106007U1 (de) * 2014-07-22 2015-07-23 Bio.Lo.Ga. S.R.L. Zusammensetzung zur Verwendung in der Vorbeugung und Behandlung allergischer Rhinitis
AU2015335204B2 (en) * 2014-10-22 2020-10-08 Hulka S.R.L. Pharmaceutical composition for use in increasing the trophism of nasal mucosa
JP2018507895A (ja) * 2015-03-18 2018-03-22 バイオヌークス スイス エスエー ヘルペスを処置するための方法において使用するためのジヒドロケルセチンを含む組成物
JP2017119669A (ja) * 2015-10-15 2017-07-06 ロート製薬株式会社 異物感改善用眼科組成物
EP3849514A1 (en) * 2018-09-12 2021-07-21 Neilos S.r.l. A composition for use in the prevention and/or treatment of epistaxis
IT202000003620A1 (it) 2020-02-21 2021-08-21 Hulka S R L Uso di una formulazione per applicazione topica per il mantenimento dell’omeostasi vaginale
WO2021195319A1 (en) 2020-03-26 2021-09-30 Plx Opco Inc. PHARMACEUTICAL CARRIERS CAPABLE OF pH DEPENDENT RECONSTITUTION AND- METHODS FOR MAKING AND USING SAME

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59216812A (ja) * 1983-05-26 1984-12-06 Dowa Yakushiyou Kk 頭髪育毛料
JP2776837B2 (ja) * 1988-08-11 1998-07-16 日本レダリー株式会社 消化性潰瘍治療剤
US5032384A (en) * 1989-01-27 1991-07-16 Block Drug Company, Inc. Compositions and method for the treatment of disease
IT1249711B (it) * 1991-09-30 1995-03-09 Boniscontro E Gazzone S R L Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici,indicate nella terapia dei tessuti superficiali.
CN1039087C (zh) * 1993-12-29 1998-07-15 昆明宏达实业有限总公司 妇科病治疗保健外用药物
IT1282778B1 (it) * 1996-05-31 1998-03-31 Giorgio Panin Vitamina "e" acetato quale prodotto per applicazione topica
JPH10231243A (ja) * 1997-02-20 1998-09-02 Sekisui Chem Co Ltd 粘膜炎症外用薬

Also Published As

Publication number Publication date
AU762860B2 (en) 2003-07-10
DE69907193T2 (de) 2004-04-08
DE69907193D1 (de) 2003-05-28
PL345500A1 (en) 2001-12-17
SK352001A3 (en) 2001-06-11
TR200100014T2 (tr) 2001-06-21
RU2003128023A (ru) 2005-04-10
CN1135975C (zh) 2004-01-28
CZ200136A3 (cs) 2001-08-15
IL140759A0 (en) 2002-02-10
TR200103710T2 (tr) 2002-06-21
ATE238051T1 (de) 2003-05-15
JP2002520281A (ja) 2002-07-09
HUP0102781A2 (hu) 2001-12-28
EP1094807A1 (en) 2001-05-02
ITMI981586A1 (it) 2000-01-10
PT1094807E (pt) 2003-08-29
NZ509129A (en) 2003-10-31
HUP0102781A3 (en) 2002-04-29
DK1094807T3 (da) 2003-08-11
RU2221561C2 (ru) 2004-01-20
EP1094807B1 (en) 2003-04-23
WO2000002554A1 (en) 2000-01-20
CN1308531A (zh) 2001-08-15
ES2196813T3 (es) 2003-12-16
AU4385899A (en) 2000-02-01
HU228921B1 (en) 2013-06-28
BR9911945A (pt) 2001-03-27
CA2336990A1 (en) 2000-01-20
CZ301019B6 (cs) 2009-10-14
NO20006719D0 (no) 2000-12-29
SK284464B6 (sk) 2005-04-01
ITMI981586A0 (it) 1998-07-10

Similar Documents

Publication Publication Date Title
NO20006719L (no) Vitamin E og estere derav for anvendelse ved topisk behandling av mukopatologier
NO20044699L (no) Vaginalpleiesammensetning
AR035637A1 (es) Betamimeticos de larga accion, procedimiento para su preparacion y su empleo como medicamentos
IS8255A (is) P38 kínasatálmar staðsettir á 5 hluta heteróhring
CY1108678T1 (el) Υγρα σκευασματα για την προληψη και αντιμετωπιση βλεννογονικων νοσων και διαταραχων
DK1385519T3 (da) Tiotropiumsalte til behandling af inflammatoriske sygdomme
MXPA03011947A (es) Formulaciones de olopatidina para administracion topica.
UA81638C2 (ru) Композиция метронидазола для местного применения для лечения заболеваний аноректального и перианального участков
NO20061214L (no) 2,4-pyrimidindiaminer nyttige i behandling av neoplastiske sykdomme,r inflammatoriske forstyrrelser og immunsystemforstyrrelser
CY1107465T1 (el) Μελαγατρανη για τη θepαπευτικη αντιμετωπιση φλεγμονων
EE200200636A (et) Dibensoasuleeni derivaadid, nende valmistamismeetodid ja kasutamine
WO2001089536A3 (en) Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
ATE360428T1 (de) Analgetisches arzneimittel
NO20040007L (no) Anvendelse av 2,5-dihydroksybenzensulfonsyrederivater ved fremstilling av medikament for a fremme effekten av andre medikamenter ved behandling av erektil dysfunksjon
SE0102639D0 (sv) Novel compounds
ATE270098T1 (de) Wirkstoff enthaltende orale oder mucosale zubereitung mit steuerbarer wirkstofffreisetzung und ihre verwendung
FR2855400B1 (fr) Dispositif rectal, notamment pour le traitement des hemorrhoides
AR026241A1 (es) Empleo de carbinoles 2-imidazolil substituidos para la preparacion de un medicamento para el tratamiento o profilaxis de enfermedades provocadas porestados isquemicos
UA41100A (uk) Вагінальний супозиторій для лікування запальних захворювань піхви та вульви
CA2591758A1 (en) Applicator for the delivery of topical formulation into mucosal cavities
RU2003117503A (ru) Способ лечения и профилактики рецидивов генитальной папилломавирусной инфекции
UA40384A (uk) Спосіб лікування хронічного гнійного верхньощелепного синуїту
UA3728U (uk) Спосіб лікування синдрому рокитанського-кюстера-майєра
UA3641U (uk) Спосіб лікування фонових захворювань шийки матки при папіломавірусній та герпетичній інфекціях
RU2002108070A (ru) Средство "Бифилиз-С" для профилактики и лечения дисбактериоза и воспалительных заболеваний органов брюшной полости и малого таза

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application